NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jingxu Venture Capital

Jingxu Venture Capital

Overview

Jingxu Venture Capital (also known as Prosperico Ventures) is a Shanghai-based venture capital firm that specializes in healthcare and high-tech industry investments, focusing on emerging companies and buyouts.

Year Founded

2015

Portfolio Companies

4

Investments

Jingxu Venture Capital investments
CompanyDateStageLead
Singlera Genomics Inc.Dec 2020Series BCo-investor
Nanjing Forssmann Medical Technology Co., Ltd.Oct 2018AngelCo-investor
Xynomic PharmaceuticalsAug 2018Series BCo-investor
Singlera Genomics Inc.Mar 2018Series A ExtensionLead
Xynomic Pharmaceuticals-Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.